Wealthcare Advisory Partners’s Catheter Precision VTAK Stock Holding History
Bought
Maintained
Sold
Other funds holding VTAK
SWM
WA
SSG
HF
TSS
APP
Wealthcare Advisory Partners's VTAK Position: Q3 2022 in Review
Wealthcare Advisory Partners sold out of Catheter Precision (VTAK) in Q3 2022, closing a stake of 1 share — an estimated $4K sold.
Wealthcare Advisory Partners first reported a position in VTAK in Q2 2022 and held it in 1 quarter. The position peaked at $4K in Q2 2022. 17 funds tracked by Wall St. Rank hold VTAK as of Q3 2022.
- Wealthcare Advisory Partners reported no remaining Catheter Precision position as of Q3 2022 after selling out during the quarter.
- Wealthcare Advisory Partners sold 1 Catheter Precision share in Q3 2022, an estimated $4K.
- Wealthcare Advisory Partners first reported a position in Catheter Precision in Q2 2022 and held it in 1 quarter.
- Wealthcare Advisory Partners's Catheter Precision position peaked at $4K in Q2 2022.
- 17 funds tracked by Wall St. Rank held Catheter Precision as of Q3 2022.
Based on Wealthcare Advisory Partners's 13F filing for Q3 2022, filed 14 Nov 2022.